The actress, 52, who was diagnosed with multiple sclerosis in 2018, said during a past relapse she 'didn't want to face' her health condition and even stopped seeing doctors. She said: 'I did have a ...

WHEN life gave Lina Nielsen lemons, she sprinted straight to the Olympics.  The 28-year-old was diagnosed with multiple sclerosis at 17 years old, leaving her terrified of disability. Doctors gave ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

According to the MS Society, in RRMS people have attacks of new and old symptoms, i.e. a relapse. RRMS is the most common type of multiple sclerosis, with other types being primary progressive MS ...

Corticosteroids (usually used for the treatment of MS relapses) prescribed most often included intravenous methylprednisolone (used in 53% of patients) and oral prednisone (used in approximately 8 ...

There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition.

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Therapy with cladribine tablets was evaluated as a short-course regimen for RRMS in the Cladribine Tablets Treating Multiple Sclerosis Orally (CLARITY) study. [46–49] CLARITY was a Phase III ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...